What is the ROE (Return on Equity) of Fagron this year?
The ROE of Fagron this year is 0.15 undefined.
Fagron ROE 2024
Fagron ROE
0.15
Ticker
FAGR.BR
ISIN
BE0003874915
WKN
A0M103
In 2024, Fagron's return on equity (ROE) was 0.15, a -11.6% increase from the 0.17 ROE in the previous year.
Fagron Aktienanalyse
What does Fagron do?
Fagron NV is an internationally operating company that focuses on the development and production of customized medications for pharmacies and hospitals. The company was founded in 1990 in Rotterdam, Netherlands. The beginnings of Fagron NV were in the Netherlands, where the company was established as Roterodamum Chemie BV. In the late 1990s, the company was converted into a holding company called Arseus NV, which later received the name Fagron. In 2012, Fagron was listed on the Euronext stock exchange in Brussels. Fagron operates globally and has locations in Europe, North America, Latin America, the United Arab Emirates, Asia, and Australia. Fagron's business model is based on the production of specialized medications for individual patient needs. The company offers a wide range of pharmaceutical active ingredients, raw materials, and processing services. There is also the possibility to develop and manufacture customized formulations tailored to the needs of patients. Fagron not only manufactures customized medications but also provides training and support for pharmacies and hospitals. Fagron operates in three main divisions: Specialty Pharma (hospital care), Community Pharma (prescription and non-prescription medications), and Compounding Services (custom formulations). The Specialty Pharma division specializes in medications for use in hospitals. It offers a wide range of products that can be used in the treatment of conditions such as cancer, HIV, and tuberculosis. These medications are manufactured in various dosage forms, such as injections, infusions, and tablets. The Community Pharma division focuses on prescription and non-prescription medications. Both branded and generic medications are offered. These are delivered directly to pharmacies, hospitals, and clinics. The Compounding Services division specializes in the production of customized medications. Fagron works closely with pharmacies and hospitals to meet individual needs. This includes, for example, the manufacture of medications in specific dosages or the combination of several active ingredients in a custom formulation. Fagron offers a wide range of products, including hormones, pain medications, cancer drugs, medications for the treatment of skin diseases, ophthalmic products, and anti-infectives. Pharmaceutical active ingredients and raw materials are also offered. Overall, Fagron is a global leader in the production of customized medications. It has extensive experience and expertise in the manufacturing of pharmaceutical formulations and offers a wide range of products and services. The various divisions of Fagron allow the company to meet the diverse needs of its customers and maintain its position as a leading company in the pharmaceutical industry. Fagron ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Fagron's Return on Equity (ROE)
Fagron's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Fagron's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Fagron's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Fagron’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Fagron stock
How has the Return on Equity (ROE) of Fagron developed compared to the previous year?
The ROE of Fagron has increased by -11.6% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Fagron?
A high ROE indicates that Fagron generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Fagron?
A low ROE can indicate that Fagron is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Fagron affect the company?
A change in ROE (Return on Equity) of Fagron can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Fagron?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Fagron?
Some factors that can influence Fagron's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Fagron pay?
Over the past 12 months, Fagron paid a dividend of 0.25 EUR . This corresponds to a dividend yield of about 1.35 %. For the coming 12 months, Fagron is expected to pay a dividend of 0.28 EUR.
What is the dividend yield of Fagron?
The current dividend yield of Fagron is 1.35 %.
When does Fagron pay dividends?
Fagron pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Fagron?
Fagron paid dividends every year for the past 0 years.
What is the dividend of Fagron?
For the upcoming 12 months, dividends amounting to 0.28 EUR are expected. This corresponds to a dividend yield of 1.54 %.
In which sector is Fagron located?
Fagron is assigned to the 'Health' sector.
Wann musste ich die Aktien von Fagron kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Fagron from 5/23/2024 amounting to 0.3 EUR, you needed to have the stock in your portfolio before the ex-date on 5/21/2024.
When did Fagron pay the last dividend?
The last dividend was paid out on 5/23/2024.
What was the dividend of Fagron in the year 2023?
In the year 2023, Fagron distributed 0.2 EUR as dividends.
In which currency does Fagron pay out the dividend?
The dividends of Fagron are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Fagron
Our stock analysis for Fagron Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fagron Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.